Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

CMS delays hospital star ratings update

Overall star ratings on the CMS Hospital Compare website will not be updated in October as previously scheduled, according to the American Hospital Association (AHA).

Inside Brigham and Women’s drive to cut $50M

STAT News was provided what it called “unusual access” to internal discussions at Boston’s Brigham and Women’s Hospital as it sought to cut $50 million from its $2.6 billion in annual spending. The dramatic overhaul went so far as to override the choice of hospitals’ nurses on mattress pads.

The financial benefits of addressing physician burnout

A healthcare organization which employs 450 physicians could realize a 12.5 percent return on a $1 million investment to tackle physician burnout, according to a study published in JAMA Internal Medicine.

Examining efforts to improve residents’ knowledge of documentation, coding

Standards on coding and clinical documentation are improved constantly, but most residency programs lack education and training. In a study published in the Journal of Surgical Education, researchers evaluated residents’ current knowledge and examined the effect of an educational session on knowledge improvement.

'The answer is money': Value-based care butting heads with prevailing culture in medicine

Saying “no” to procedures and treatments, even when they’ve been shown not to be helpful to patients, is easier said than done for physicians, threatening efforts like the Choosing Wisely initiative begun by the American Board of Internal Medicine.

Thumbnail

Healthcare groups tell Congress to move on ‘for good’ from ACA repeal

Major healthcare associations said they were relieved by Senate Republicans’ decision to table the Graham-Cassidy legislation to repeal the Affordable Care Act (ACA), bringing at least a temporary halt to the party’s efforts to replace the law with only Republican votes.

267,000 healthcare jobs would be eliminated under latest ACA repeal plan

The Graham-Cassidy legislation to repeal the Affordable Care Act (ACA) would cause an immediate downturn in healthcare employment, amounting to more than 267,000 fewer jobs in the industry by 2026, according to a report from George Washington University’s Milken Institute School of Public Health and the Commonwealth Fund.

Thumbnail

Graham-Cassidy ACA repeal bill tabled: ‘We’re coming back to this’

Senate Republicans have decided not to vote on the Graham-Cassidy legislation to repeal the Affordable Care Act (ACA), putting an end to months of efforts to pass a repeal bill before a Sept. 30 deadline for it to clear the Senate with a simple majority.

Displaying 4193 - 4200 of 6649

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup